Search all medical codes

Unclassified biologics

HCPCS code

Medical Policies and Guidelines for Unclassified biologics

Related policies from health plans

Adzynma (ADAMTS13, recombinant-krhn)
Adbry (tralokinumab)
Aphexda (motixafortide)
Aphexda (motixafortide)
BESREMi (ropeginterferon alfa-2b-njft)
Beta Interferons and Glatiramer Acetate for Treatment of Multiple Sclerosis
Beta Interferons and Glatiramer Acetate for Treatment of Multiple Sclerosis
Bevacizumab for Non-Ophthalmologic Indications
Bevacizumab for Non-Ophthalmologic Indications
Botulinum Toxin
Botulinum Toxin
Cablivi (caplacizumab-yhdp )
Colony Stimulating Factor Agents
Complement Inhibitors
Dupixent (dupilumab)
Egrifta (tesamorelin)
Egrifta (tesamorelin)
Growth Hormone
Growth Hormone
Izervay (avacincaptad pegol)
Interleukin-1 Inhibitors
Interleukin-1 Inhibitors
Breast Reconstruction Following Mastectomy or Lumpectomy - (0178)
Breast Reconstruction Following Mastectomy or Lumpectomy - (0178)
Melanoma Vaccines
Monoclonal Antibodies to Interleukin-23
Monoclonal Antibodies to Interleukin-23
Monoclonal Antibodies to Interleukin-17
Monoclonal Antibodies to Interleukin-6
Palynziq (pegvaliase-pqpz)
Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibitors
Rituximab agents for Non-Oncologic Indications
Spevigo (spesolimab-sbzo)
Injectable Fillers - (0511)
Tumor Necrosis Factor Antagonists
Tumor Necrosis Factor Antagonists
Uplizna (inebilizumab-cdon)
Vascular Endothelial Growth Factor (VEGF) Inhibitors
Collagenase Ointment (Santyl) (PG141)
Botulinum Toxin (CG033)
Dupixent (dupilumab) (PG026)
Elevidys (delandistrogene moxeparvovec-rokl) (PG160)
Experimental and Investigational Services (CG012)
Lamzede (velmanase alfa-tycv) (PG146)
Izervay (avancincaptad pegol) (PG168)
Omisirge (omidubicel-onlv) (PG149)
Roctavian (valoctocogene roxaparvovec-rvox) (PG163)
Vyjuvek (beremagene geperpavec-svdt) (PG147)
Ycanth (cantharidin) (PG162)
Lantidra
Thymus Tissue Transplantation - (0561)
Tissue Engineered Skin Substitutes - (0068)
Tissue Engineered Skin Substitutes - (0068)
Tissue Engineered Skin Substitutes - (0068)
Tissue Engineered Skin Substitutes - (0068)
MED.00147 Cellular Therapy Products for Allogeneic Stem Cell Transplantation
MED.00135 Gene Therapy for Hemophilia
MED.00142 Gene Therapy for Cerebral Adrenoleukodystrophy
MED.00144 Gene Therapy for Duchenne Muscular Dystrophy
TRANS.00038 Thymus Tissue Transplantation
Allogenic Processed Thymus Tissue-agdc (Rethymic)
Tralokinumab-ldrm (Adbry)

Similar Codes


ICD10CM codes

Z92.859 - Personal history of cellular therapy, unspecified
Y64.9 - Contaminated medical or biological substance administered by unspecified means
Z88.9 - Allergy status to unspecified drugs, medicaments and biological substances
Z52.001 - Unspecified donor, stem cells
Y64 - Contaminated medical or biological substances
Y36.6X - War operations involving biological weapons
T50.Z94A - Poisoning by other vaccines and biological substances, undetermined, initial encounter
Y37.6X - Military operations involving biological weapons
Z29.1 - Encounter for prophylactic immunotherapy
Y36.6 - War operations involving biological weapons

HCPCS codes

J3590 - Unclassified biologics
C9399 - Unclassified drugs or biologicals
J3490 - Unclassified drugs
J7599 - Immunosuppressive drug, not otherwise classified
J7999 - Compounded drug, not otherwise classified
J9999 - Not otherwise classified, antineoplastic drugs
L8499 - Unlisted procedure for miscellaneous prosthetic services
J3473 - Injection, hyaluronidase, recombinant, 1 usp unit
J0490 - Injection, belimumab, 10 mg
D9630 - OTHER DRUGS AND/OR MEDICAMENTS

CPT4 codes

90399 - Unlisted immune globulin
86849 - Unlisted immunology procedure
90749 - Unlisted vaccine/toxoid
95199 - Unlisted allergy/clinical immunologic service or procedure
85999 - Unlisted hematology and coagulation procedure
96549 - Unlisted chemotherapy procedure
86999 - Unlisted transfusion medicine procedure
87999 - Unlisted microbiology procedure
89240 - Unlisted miscellaneous pathology test
97139 - Unlisted therapeutic procedure (specify)